Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Apellis Pharma
3103
Apellis Pharma
Technology
Biotechnology
Small Biotech Focusing on Complement Immunotherapy
Suggest edits
Founded
2008
Raised
$139.1M
Follow us
Companies in the same industry
Rgenix
Icagen, Inc.
Khepri
Cardia
Advanced BioCatalytics Corporation
SeqWell Inc
Embera NeuroTherapeutics
Pyxant Labs Inc.
Aptevo Therapeutics
PolyLabs
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$60,000,000
Venture capital (Series E) - 2017
Epidarex Capital
Sofinnova Ventures
Cormorant Asset Management
+6
$47,100,000
Venture capital (Series D) - 2016
Hillhouse Capital Group
Epidarex Capital
Cormorant Asset Management
+3
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$60,000,000
Venture capital (Series E)
bizjournals
,
businesswire
https://www.bizjournals.com/louisville/news/2017/08/10/local-company-gets-60-million-in-financing.html?ana=twt
$47,100,000
Venture capital (Series D)
FinSMEs
Apellis Pharmaceuticals Completes $47.1M Series D Financing
Health
Funding
$32,000,000
Venture capital (Series D)
venturedeal
Apellis Pharma Accepts $32 Million Equity VC
